NovoCure Ltd. (NVCR)
Market Closed
15 Oct, 08:00 PM
$
14. 41
+0.57
+4.1185%
After Hours
$
+0.39 +2.7065% 14. 80
1.61B Market Cap
- P/E Ratio
- Div Yield
1.69M Volume
-2.03 Eps
$ 13.84
Previous Close 
Want to track NVCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NovoCure Ltd. (NVCR) Statistics
Valuation metrics
Market Cap 1.61B
Enterprise value 1.84B
Trailing P/E (ttm) -11.22
Forward P/E -15.33
PEG ratio -3.54
Price/Sales (ttm) 2.43
Price/Book (mrq) 5
Enterprise Value/Revenue 2.63
Enterprise Value/EBITDA -13.85
Overview
Shares outstanding 115.82M
Float 95.36M
Shares short 6.97M
% Held by insiders 0.1%
% Held by institutions 0.88%
Average volume (10 days) 1.02M
Average volume (90 days) 1.5M
Price summary
52-Week low 9.82
52-Week high 21.45
Beta 0.9
50-Day moving average 16.58
200-Day moving average 14.75
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.21%
Operating margin -0.22%
Operational effectiveness
Return on assets -0.19%
Return on equity -0.44%
Income Statement
Revenue (ttm) 674.41M
Revenue per share (ttm) 6.03
Quarterly revenue growth (yoy) 0.12%
Gross profit (ttm) 508.84M
EBITDA -166.22M
Net income to common (ttm) -173.05M
Diluted EPS (ttm) -1.28
Quarterly earnings growth (yoy) 0.12%
Balance Sheet
Total cash (mrq) 432M
Total cash per share (mrq) 3.8
Total debt (mrq) 234.94M
Total Debt/Equity (mrq) 0.69
Current ratio (mrq) 2.89%
Book value per share (mrq) 2.91
Cash Flow
Cash flow statement -26.88M
Levered free cash flow (LFCF) 5.08M
2026 © Marketlog. All Rights Reserved.
